M42’s Imperial College London Diabetes Centre and HealthPlus Diabetes & Endocrinology Center seek to advance diabetes care at the second annual Diabetes Conference
For the second consecutive year, Imperial College London Diabetes Centre (ICLDC) and HealthPlus Diabetes & Endocrinology Center, part of the M42 group, will co-host the annual Diabetes Conference. Held at the Four Seasons Hotel, Abu Dhabi from 9 - 10 November, the event follows the highly successful inaugural conference in 2023.
Last year, more than 400 delegates engaged in dynamic discussions, presentations and workshops, led by subject matter experts from across the globe. Topics ranged from advances in continuous glucose monitoring (CGM) devices to the management of type 1 diabetes using stem cells or artificial pancreases. Recognizing the urgent need for comprehensive diabetes management, this year's conference featured collaborative opportunities for local and international healthcare networks to enhance knowledge exchange and foster partnerships. The event aimed to empower regional healthcare professionals with evidence-based insights, curated programs and expert-led workshops. Key sessions focused on managing type 1 and type 2 diabetes, featuring a debate on low-calorie diets, along with panels on cardiovascular disease, diabetic eye complications and kidney health. Additional workshops explored CGM interpretation and the role of technology in diabetes care.
Professor Maha Barakat, Assistant Minister for Health and Life Sciences at the UAE Ministry of Foreign Affairs, provided delegates with the latest updates on diabetes guidelines, which set the tone for evidence-based care at the conference’s outset.
Professor Amir Sam, consultant endocrinologist and Head of the School of Medicine at Imperial College London - and chair of the Conference, said: “With more than 73 million people living with diabetes in the MENA region2, there is an urgent need to advance diabetes care. Working with healthcare leaders at the forefront of diabetes care, we are honored to co-organize the annual Diabetes Conference for the second consecutive year, providing healthcare leaders with the opportunity to learn from peers and explore the latest developments and advancements in diabetes care. It is imperative that all stakeholders in the diabetes arena collaborate to drive progress in diagnosis, evaluation and treatment to reduce the prevalence of the disease and improve patient outcomes.”
Dr. Mustafa Khan, Medical Director at Imperial College London Diabetes Centre, said, “It gave us great pride to host our colleagues from UK and work together with HealthPlus Diabetes & Endocrinology Center for the benefit of all involved in the fight against diabetes. In coming together to share experiences, insights and best practices, we give ourselves the best possible chance to drive progress towards reducing the prevalence of diabetes and reinforce our position as a leader in diabetes healthcare in the region and further afield.”
Dr. Huda Ezzeddin, Consultant Diabetes & Endocrinology at HealthPlus Diabetes & Endocrinology Center, added: “Following our successful inaugural conference in 2023, we believe that advancing diabetes care requires equipping healthcare professionals with the right training and tools. This conference offered an exceptional educational experience, featuring insights into the latest technologies and treatment advancements from both regional and international experts to help tackle this chronic disease that affects so many people around the world.”
International experts from Imperial College London, UK, in attendance at the conference included Professor Ketan Dhatariya, author of the globally recognized diabetes guidelines
